精确的一般化I-II阶段设计
Saijun Zhao1, Peter F Thall2, Ying Yuan2
1Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Biometrics
|July 24, 2025
概括
精确贝叶斯剂量优化设计 (PGen I-II) 通过考虑患者子组来改善临床试验. 这种方法通过考虑早期疗效,毒性和长期结果来优化药物剂量,以获得更好的治疗成功.
科学领域:
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 传统的临床试验设计往往忽视了患者的异质性.
- 优化药物剂量需要平衡疗效,毒性和患者的长期结果.
研究的目的:
- 为了引入一种新的精确贝叶斯剂量优化设计,PGen I-II.
- 通过纳入患者子组分析来完善现有的剂量确定方法.
主要方法:
- PGen I-II设计利用早期疗效和毒性数据进行适应剂量调整.
- 它使用具有子组特异效应的断片指数分布来建模长期治疗失败.
- 隐性变量用于具有相似剂量-结果配置文件的子组的自适应集群.
主要成果:
- 在模拟中,PGen I-II设计表现出优于假设患者同质性或单独子组试验的设计.
- 它可以为分组特定的决定进行剂量升级,降级或随机化.
- 该模型允许类似子组之间的借贷力来增强统计能力.
结论:
- PGen I-II设计为临床试验中剂量优化提供了更精确,更适应的方法.
- 通过子组分析来考虑患者异质性,可以提高治疗成功率.
- 易于使用的软件和指导方针有助于实现这种先进的设计.
更多相关视频
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Drug Metabolism: Phase I Reactions
3.6K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.6K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Phase I Oxidative Reactions: Overview
379
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
379
Crossover Experiments
3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K


